# Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler

> **NCT01463410** · — · TERMINATED · sponsor: **Skyline Diagnostics BV** · enrollment: 264 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Refractory Anemia With Excess of Blasts (RAEB)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01463410
- **Lead sponsor:** Skyline Diagnostics BV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 264 (ACTUAL)
- **Why stopped:** The required number of banked samples could not be met due to limited availability. There is no realistic possibility to complete the study succesfully.
- **Last updated:** 2013-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01463410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01463410, "Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01463410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*